TGTX EBITDA

Tg Therapeutics Inc · EBITDA

TGTX logo

TGTX EBITDA

Latest reported$134.26M
TGTX TTM EBITDA (-$2.80M → $134.26M)
High-resolution chart · PNG

TGTX ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Tg Therapeutics Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
134,264,000
150,189,000
134,361,000
115,244,000
97,716,000
70,621,000
50,032,000
5,953,000
108,558,000
54,060,000
26,101,000
-12,402,000
-164,212,000
-157,676,000
-187,629,000
-229,749,000
-280,178,000
-319,569,000
-341,967,000
-336,662,000
-337,651,000
-311,464,000
-272,677,000
-223,456,000
-198,318,000
-182,865,000
-167,393,000
-183,919,000
-157,526,000
-166,534,000
-173,732,000
-150,621,000
-148,257,000
-132,540,000
-118,629,000
-111,056,266
-104,398,592
-92,001,096
-78,340,872
-72,533,481
-61,032,023
-61,878,790
-62,493,446
-63,578,218
-67,611,800
-62,713,174
-55,432,945
-41,890,971
-28,767,861
-23,441,787
-19,563,608
-16,971,707
-15,137,983
-8,509,412
-22,243,777
-22,720,970
-20,269,233
-20,566,233
-8,643,095
-6,025,942
-7,341,598
-7,568,102
-2,843,500
-2,737,775
-1,786,646
-1,738,915
-1,766,026
-1,370,838
-2,352,363
-3,336,137
-4,386,596
-6,352,514
-7,673,172
-11,123,537
-12,095,612
-13,349,387
-12,603,149
-10,035,901
-9,940,141
-21,289,747
-21,201,023
-20,346,061
-19,287,899
-6,523,828
-6,865,196
-6,329,072
-6,014,679
-5,782,895
-5,569,616
-5,298,877
-4,569,107
-3,404,783
-1,990,281
-1,558,241
-1,796,417
-1,989,380
-2,107,581
-3,315,150
-2,894,211
-5,477
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.